Cargando…
Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple prim...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890551/ https://www.ncbi.nlm.nih.gov/pubmed/27254665 http://dx.doi.org/10.1038/srep23252 |
_version_ | 1782435125561131008 |
---|---|
author | Zhang, Zhirong Gao, Shugeng Mao, Yousheng Mu, Juwei Xue, Qi Feng, Xiaoli He, Jie |
author_facet | Zhang, Zhirong Gao, Shugeng Mao, Yousheng Mu, Juwei Xue, Qi Feng, Xiaoli He, Jie |
author_sort | Zhang, Zhirong |
collection | PubMed |
description | The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple primary NSCLC who underwent radical surgical resection and with complete follow-up information were included in this study. The Kaplan-Meier method were used for survival analysis, Cox proportional hazards regression models were used for risk factors evaluation. Among them, 94 (33.0%) patients had bilateral tumors and 51 (17.9%) had multiple (≥3) tumors. The 5-year disease-free survival (DFS) and overall survival (OS) rate was 58.7% and 77.6%, respectively. Univariate analysis identified parameters conferring shorter OS including male gender, symptomatic disease, negative family history, large maximal tumor size, not all adenocarcinomas, advanced highest T stage, and lymph node involvement. Multivariate analysis showed that male gender (p = 0.020), symptomatic disease (p = 0.017), and lymph node involvement (p < 0.001) were independent adverse prognosticators. For patients with multiple adenocarcinomas, the 5-year DFS and OS rate was 59.6% and 82.4%, respectively. The subtypes other than lepidic predominant (p < 0.001) and lymph node involvement (p = 0.002) were the independent unfavorable prognosticators. In conclusion, we identified independent prognosticators which will provide the valuable clues for postoperative management of patients with synchronous multiple primary NSCLC. |
format | Online Article Text |
id | pubmed-4890551 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-48905512016-06-09 Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers Zhang, Zhirong Gao, Shugeng Mao, Yousheng Mu, Juwei Xue, Qi Feng, Xiaoli He, Jie Sci Rep Article The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple primary NSCLC who underwent radical surgical resection and with complete follow-up information were included in this study. The Kaplan-Meier method were used for survival analysis, Cox proportional hazards regression models were used for risk factors evaluation. Among them, 94 (33.0%) patients had bilateral tumors and 51 (17.9%) had multiple (≥3) tumors. The 5-year disease-free survival (DFS) and overall survival (OS) rate was 58.7% and 77.6%, respectively. Univariate analysis identified parameters conferring shorter OS including male gender, symptomatic disease, negative family history, large maximal tumor size, not all adenocarcinomas, advanced highest T stage, and lymph node involvement. Multivariate analysis showed that male gender (p = 0.020), symptomatic disease (p = 0.017), and lymph node involvement (p < 0.001) were independent adverse prognosticators. For patients with multiple adenocarcinomas, the 5-year DFS and OS rate was 59.6% and 82.4%, respectively. The subtypes other than lepidic predominant (p < 0.001) and lymph node involvement (p = 0.002) were the independent unfavorable prognosticators. In conclusion, we identified independent prognosticators which will provide the valuable clues for postoperative management of patients with synchronous multiple primary NSCLC. Nature Publishing Group 2016-06-02 /pmc/articles/PMC4890551/ /pubmed/27254665 http://dx.doi.org/10.1038/srep23252 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zhang, Zhirong Gao, Shugeng Mao, Yousheng Mu, Juwei Xue, Qi Feng, Xiaoli He, Jie Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title | Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title_full | Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title_fullStr | Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title_full_unstemmed | Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title_short | Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers |
title_sort | surgical outcomes of synchronous multiple primary non-small cell lung cancers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890551/ https://www.ncbi.nlm.nih.gov/pubmed/27254665 http://dx.doi.org/10.1038/srep23252 |
work_keys_str_mv | AT zhangzhirong surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT gaoshugeng surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT maoyousheng surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT mujuwei surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT xueqi surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT fengxiaoli surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers AT hejie surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers |